SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-007205
Filing Date
2024-02-27
Accepted
2024-02-27 16:07:19
Documents
106
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bcrx-20231231.htm   iXBRL 10-K 2174869
2 EX-21 exhibit21-subsidiaries1.htm EX-21 8156
3 EX-23 exhibit23-202310xkxdraftco.htm EX-23 6689
4 EX-31.1 bcrx-20231231xex311.htm EX-31.1 9749
5 EX-31.2 bcrx-20231231xex312.htm EX-31.2 9746
6 EX-32.1 bcrx-20231231xex321.htm EX-32.1 6019
7 EX-32.2 bcrx-20231231xex322.htm EX-32.2 5515
8 EX-97 exhibit97-nasdaqcompliantc.htm EX-97 10449
14 GRAPHIC bcrx-20231231_g1.jpg GRAPHIC 106862
  Complete submission text file 0001628280-24-007205.txt   11449132

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20231231.xsd EX-101.SCH 81669
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20231231_cal.xml EX-101.CAL 96910
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20231231_def.xml EX-101.DEF 371075
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20231231_lab.xml EX-101.LAB 994178
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20231231_pre.xml EX-101.PRE 655979
108 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20231231_htm.xml XML 1669431
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 24686601
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)